Drugs / PF-08642534
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07575945 | May → Jun 2026 overdue | — | Pfizer | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PF-08642534 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07575945 ↗ |
| Route | Oral | “single oral doses of PF-08642534” NCT07575945 ↗ |